drugset / Trial / NCT05954611
The Study of Single Dose Administration of GR2002 Injection in Chinese Health Volunteers
RandomizedParallel-groupQuadruple-blindTreatment
Summary
To evaluate the pharmacokinetic (PK) characteristics and pharmacological effect of GR2002 injection in Chinese healthy volunteers
Timeline
- Start
- 2023-06-16
- Primary completion
- 2024-01-02
- Completion
- 2024-01-02
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | GR2002 | Monoclonal antibody | 35 mg | Subcutaneous |